BAC
BAC's valuation is somewhat elevated, fundamentals are above averages and forward estimates point to earnings growth and improving margins.
BAC vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 14x | 12x | 24% higher+24% |
| PE percentile | 85 | 50 | 71% higher+71% |
| EPS | $4.34 | $3.14 | 38% higher+38% |
| FCF | $94.7B | $14.3B | 561% higher+561% |
| Loading historical comparisons… | |||
BAC’s earnings and cash flow are above their historical averages, while its earnings multiple is higher.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Strong decline |
| Forward profitability | Strongly expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Tight |
BAC’s outlook is generally improving, with declining sales expectations a concern.
BAC PE Valuation
This table applies BAC's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
BAC Earnings Per Share
This chart tracks BAC's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
BAC Quarterly Revenue
This chart tracks BAC's quarterly revenue over time and shows how sales are changing from year to year.
BAC Free Cash Flow
This chart tracks BAC's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
BAC Total Shares
This chart tracks changes in BAC's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
BAC Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
BAC PE vs Financial Services Sector
This chart compares BAC's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
BAC Weekly Price
This chart uses BAC's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
BAC Weekly Moving Averages
This chart compares BAC's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
BAC Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
IVZ
IVZ's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins, though analyst coverage is limited.
IVZ vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 18x | 11x | 65% higher+65% |
| PE percentile | 90 | 50 | 80% higher+80% |
| EPS | -$0.68 | $1.00 | 168% lower-168% |
| FCF | $2B | $1.1B | 85% higher+85% |
| Loading historical comparisons… | |||
IVZ’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.
IVZ Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Strong growth |
| Forward revenue | Decline |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
IVZ’s outlook is generally improving, with declining sales expectations a concern.
IVZ PE Valuation
This table applies IVZ's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
IVZ Earnings Per Share
This chart tracks IVZ's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
IVZ Quarterly Revenue
This chart tracks IVZ's quarterly revenue over time and shows how sales are changing from year to year.
IVZ Free Cash Flow
This chart tracks IVZ's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
IVZ Total Shares
This chart tracks changes in IVZ's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
IVZ Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
IVZ PE vs Financial Services Sector
This chart compares IVZ's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
IVZ Weekly Price
This chart uses IVZ's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
IVZ Weekly Moving Averages
This chart compares IVZ's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
IVZ Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.